Home / Press Release  / Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged Prostate

Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged Prostate

- Advanced steam-based therapy brings rapid relief for enlarged prostate, requiring minimal anesthesia and short hospital stay, with minimal morbidity. New Delhi, September 14, 2026: Fortis Hospital, Shalimar Bagh has launched Rezūm™ Water Vapor Therapy, becoming

Water vapour theray

Advanced steam-based therapy brings rapid relief for enlarged prostate, requiring minimal anesthesia and short hospital stay, with minimal morbidity.

New Delhi, September 14, 2026: Fortis Hospital, Shalimar Bagh has launched Rezūm™ Water Vapor Therapy, becoming the first multi-speciality hospital in Delhi NCR to introduce the advanced, minimally invasive treatment for men suffering from Lower Urinary Tract Symptoms (LUTS) caused by benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate .

Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that commonly affects aging men. In India, prevalence studies indicate that approximately 25% of men aged between 40 to 49 years, 37% of men aged 50 – 60 years, and over 50% of men above 60 years suffer from BPH-related symptoms. The introduction of Rezūm™ technology at Fortis Shalimar Bagh, addresses an essential clinical need for patients across Delhi and North India seeking an effective alternative to traditional surgical interventions and lifelong medication.

Rezūm™ Water Vapor Therapy uses controlled steam to shrink excess prostate tissue and relieve urinary blockages. Performed as a minimally invasive day-care procedure, typically without general anaesthesia, it enables faster recovery and an early return to routine activities. Compared with conventional surgical options, Rezūm™ carries a lower risk of sexual dysfunction, thereby helping preserve sexual health and quality of life. It may also be considered for patients taking blood-thinning medication, following appropriate medical evaluation. Five-year clinical data shows sustained symptom relief, with only 4.4% of patients requiring a follow-up surgery.

Dr. Anurag Puri, Additional Director – Urology, Fortis Hospital, Shalimar Bagh, said, “An enlarged prostate significantly impacts a man’s quality of life, leading to frequent urination, sleep disruptions, and urinary retention. Many patients hesitate to undergo traditional surgery due to concerns regarding hospital stay, bleeding or the loss of sexual function. Rezūm™ Water Vapor Therapy is a game-changer as it uses natural steam to treat targeted tissue in minutes, requires minimal anaesthesia, and preserves sexual function. Additionally, it offers a safe, feasible alternative for higher-risk individuals, including those on blood-thinning medications or have electrolyte abnormalities. Patients can be discharged the same day after the procedure.”

Mr. Naveen Sharma, Vice President & Facility Director, Fortis Hospital, Shalimar Bagh, said, “At Fortis Hospital, Shalimar Bagh, our priority has always been to introduce world-class, patient-centric clinical innovations that elevate healthcare standards. By becoming the first hospital in Delhi to adopt Rezūm™ Water Vapor Therapy, we are providing patients in Delhi and the wider North Indian region access to next-generation urological care. This launch reinforces our commitment to offering cutting-edge, minimally invasive treatments that ensure faster healing, safety, and superior clinical outcomes.”

About Fortis Healthcare Limited

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and day care specialty facilities. Currently, the company operates 36 healthcare facilities (including JVs and O&M facilities) across 12 states and union territories. The Company’s network comprises over 6,150 operational beds (including O&M beds) and 400 diagnostics labs.

ABOUT IHH HEALTHCARE (“IHH”)

IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 70,000-strong team delivers world-class excellence every day, within and beyond our 140 healthcare facilities, including more than 80 hospitals. Our comprehensive services span the full healthcare continuum, from primary and ambulatory to quaternary care, complemented by diagnostics, imaging, rehabilitation, telehealth and home care. In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network. www.ihhhealthcare.com

medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter Popup
MedgateToday

Every major healthcare update,
delivered to your inbox

Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.

🔒 No spam. Unsubscribe anytime.